s41398-019-0481-y.pdf (1021.81 kB)
A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disorders
Version 2 2023-06-12, 09:05
Version 1 2023-06-09, 17:36
journal contribution
posted on 2023-06-12, 09:05 authored by Christopher Rayner, Jonathan R I Coleman, Kirstin L Purves, John Hodsoll, Kimberley Goldsmith, Georg W Alpers, Evelyn Andersson, Volker Arolt, Julia Boberg, Susan Bogels, Cathy Creswell, Peter Cooper, Charles Curtis, Jürgen Deckert, Katharina Domschke, Samir El Alaoui, Lydia Fehm, Thomas Fydrich, Alexander L Gerlach, Anja Grocholewski, Kurt Hahlweg, Alfons Hamm, Erik Hedman, Einar R Heiervang, Jennifer L Hudson, Peter Jöhren, Robert Keers, Tilo Kircher, Thomas Lang, Catharina Lavebratt, Sang-hyuck Lee, Kathryn LesterKathryn Lester, Nils Lindefors, Jürgen Margraf, Maaike Nauta, Christiane A Pané-Farré, Paul Pauli, Ronald M Rapee, Andreas Reif, Winfried Rief, Susanna Roberts, Martin Schalling, Silvia Schneider, Wendy K Silverman, Andreas Ströhle, Tobias Teismann, Mikael Thastum, Andre Wannemüller, Heike Weber, Hans-Ulrich Wittchen, Christiane Wolf, Christian Rück, Gerome Breen, Thalia C EleyMajor depressive disorder (MDD) and anxiety disorders are highly prevalent, disabling and moderately heritable. Depression and anxiety are also highly comorbid and have a strong genetic correlation (rg˜1). Cognitive behavioural therapy (CBT) is a leading evidence-based treatment, but has variable outcomes. Currently, there are no strong predictors of outcome. Therapygenetics research aims to identify genetic predictors of prognosis following therapy. We performed genome-wide association meta-analyses of symptoms following cognitive behavioural therapy of: adults with anxiety disorders (n=972), adults with major depressive disorder (n=832) and children with anxiety disorders (n=920; meta-analysis n=2,724). We estimated the variance in therapy outcomes that could be explained by common genetic variants (h2SNP) and polygenic scoring was used to examine genetic associations between therapy outcomes and psychopathology, personality and learning. No single nucleotide polymorphisms (SNPs) were strongly associated with treatment outcomes. No significant estimate of h2SNP could be obtained, suggesting the heritability of therapy outcome is smaller than our analysis was powered to detect. Polygenic scoring failed to detect genetic overlap between therapy outcome and psychopathology, personality or learning. This study is the largest therapygenetics study to date. Results are consistent with previous, similarly powered genome-wide association studies of complex traits.
History
Publication status
- Published
File Version
- Published version
Journal
Translational PsychiatryISSN
2158-3188Publisher
Springer NatureExternal DOI
Issue
150Volume
9Page range
1-13Department affiliated with
- Psychology Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2019-04-24First Open Access (FOA) Date
2019-05-23First Compliant Deposit (FCD) Date
2019-04-17Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC